Philip Morris International Inc

• PM Stock Price 24h change: +0.97%. From 167.18 USD to 168.81 USD.Reason: The stock rebounded along with the broader market as trade tensions eased; investor sentiment was also bolstered by positive expectations regarding the FDA's upcoming public meeting on Zyn's reduced-risk marketing claims.
• From a technical perspective, PM is in a "Strong Bullish" phase: the stock is trading above its 5-day (167.04), 50-day (168.31), and 200-day (160.61) moving averages. While the 14-day RSI of 52.4 indicates a neutral momentum, the overall trend remains positive despite recent consolidation, with key resistance near the 170 USD level.
• The FDA is holding a public meeting on January 22 to consider whether Philip Morris can advertise Zyn nicotine pouches as a "less-harmful alternative" to cigarettes, a move that could significantly boost U.S. sales.• Philip Morris recently expanded its partnership with Scuderia Ferrari HP to promote its "smoke-free" vision on a global sports platform.• Wealth Enhancement Advisory Services increased its stake in PM by 10.3% in the third quarter, reflecting continued institutional confidence in the company's smoke-free transformation.
• The World Health Organization (WHO) reported that while global tobacco use is declining, the industry is missing international targets for reduction, leading to calls for stricter control policies.• Bank of America named the tobacco sector a "top pick" for 2026, citing strong cash flow and the growth potential of next-generation products like nicotine pouches despite increased regulatory scrutiny in the EU.

• PM Stock Price 24h change: -3.71%. From 173.62 USD to 167.18 USD. This decline followed a target price reduction by Jefferies from $220 to $180, citing concerns over 2026 growth potential amid rising competition in the U.S. nicotine pouch market.
• From a technical perspective, the stock is showing "short-term oversold signals within a mid-term bullish structure." While the 20-day SMA remains above the 60-day SMA, the RSI (14) has dropped near 40 and Stochastic indicators are in oversold territory, suggesting a potential near-term rebound if support at $166 holds.
• Philip Morris International released a white paper on the future of "Human Cognition" in the age of AI, repositioning itself as a broader tech-forward consumer company while its smoke-free products now account for 41% of net revenues.
• The company unveiled a major $20 billion+ U.S. investment plan through 2026 to expand manufacturing for ZYN nicotine pouches and the IQOS heated tobacco system, aiming to create 2,500 jobs.
• Jefferies downgraded PM to "Hold," noting that while its smoke-free transformation is leading the industry, rivals like British American Tobacco and Japan Tobacco are aggressively expanding their U.S. market share.
• A major tobacco firm launched a legal challenge against the Canadian government over a new "tobacco cost recovery fee" set to start in November, labeling it an unconstitutional tax on legal manufacturers.
• British American Tobacco (BAT) announced the closure of its sole manufacturing plant in South Africa, citing a surge in illicit cigarette trade which now controls an estimated 75% of the local market.